| ADHD | Attention-deficit hyperactivity disorder | |
| AEDs | Antiepileptic drugs | |
| ALA | Alpha-linolenic acid | |
| ARA | Arachidonic acid | |
| ASD | Autism spectrum disorder | |
| BBB | Blood–brain barrier | |
| BDNF | Brain-derived neurotrophic factor | |
| CO2 | Carbon dioxide | |
| COX-2 | Cyclooxygenase-2 | |
| CXCL | C-X-C motif chemokine ligand | |
| DHA | Docosahexaenoic acid | |
| EGCG | Epigallocatechin gallate | |
| EPA | Eicosapentaenoic acid | |
| GABA | Gamma-aminobutyric acid | |
| GI | Gastrointestinal | |
| HO-1 | Heme oxygenase-1 | |
| IFN-γ | Interferon-gamma | |
| IL | Interleukin | |
| iNOS | Inducible Nitric oxide synthase | |
| Jak/STAT | Janus kinase/signal transducer and activator of transcription | |
| MAPK | Mitogen-activated protein kinase | |
| mTOR | Mechanistic target of rapamycin | |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells | |
| NMDA | N-methyl-D-aspartate | |
| nNOS | Neuronal nitric oxide synthase | |
| Nrf1/2 | Nuclear factor erythroid 2-related factor 1/2 | |
| P2X7R | P2X purinoceptor 7 receptor | |
| PI3K/Akt/GSK-3β | Phosphoinositide 3-kinase/Protein kinase B/Glycogen synthase kinase-3 beta | |
| PPARγ | Peroxisome proliferator-activated receptor gamma | |
| PTEN | Phosphatase and tensin homolog | |
| PTZ | Pentylenetetrazole | |
| PUFAs | Polyunsaturated fatty acids | |
| ROS | Reactive oxygen species | |
| SCFAs | Short-chain fatty acids | |
| SE | Status epilepticus | |
| THIK1 | Tandem pore domain halothane-inhibited K+ channel 1 | |
| TLR | Toll-like receptor | |
| TNF | Tumor necrosis factor | |
| VEGF | Vascular endothelial growth factor | |